Trends in Visits to Substance Use Disorder Treatment Facilities in 2020
Overview
Authors
Affiliations
Objective: To describe weekly changes in the number of substance use disorder treatment (SUDT) facility visits in 2020 compared to 2019 using cell phone location data.
Methods: We calculated the percentage weekly change in visits to SUDT facilities from the week of January 5 through the week of October 11, 2020, relative to the week of January 6 through the week of October 13, 2019. We stratified facilities by county COVID-19 incidence per 10,000 residents in each week and by 2018 fatal drug overdose rate. Finally, we conducted a multivariable linear regression analysis examining percent change in visits per week as a function of county-level COVID-19 tercile, a series of calendar month indicators, and the interaction of county-level COVID-19 tercile and month. We repeated the regression analysis replacing COVID-19 tercile with overdose tercile.
Results: Beginning the eleventh week of 2020, the number of visits to SUDT facilities declined substantially, reaching a nadir of 48% of 2019 visits in early July. In contrast to January, there were significantly fewer visits in 2020 compared to 2019 in all subsequent months (p < 0.01 in all months). Multivariable regression results found that facilities in the tercile of counties experiencing the most COVID-19 cases had a significantly greater reduction in the number of SUDT visits in 2020 for the months of June through August than facilities in counties with the fewest COVID-19 rates (p < 0.05). The study found no statistically significant difference in the change in the number of visits by facilities in counties with historically different overdose rates.
Discussion: Our findings support the hypothesis that a reduction has occurred in the average weekly number of visits to SUDT facilities. The size of the effect differs based on the number of COVID-19 cases but not on historical overdose rate.
Baloh J, Charton H, Curran G Subst Use Misuse. 2023; 58(14):1855-1865.
PMID: 37722809 PMC: 10872742. DOI: 10.1080/10826084.2023.2257305.
Feder K, Patel E, Buresh M, Kirk G, Mehta S, Genberg B Drug Alcohol Depend. 2023; 251:110954.
PMID: 37716287 PMC: 10538370. DOI: 10.1016/j.drugalcdep.2023.110954.
Whinkin E, Eparwa T, Julseth M, Schneider A, Aggarwal S Front Psychiatry. 2023; 14:1160442.
PMID: 37711421 PMC: 10498542. DOI: 10.3389/fpsyt.2023.1160442.
Mahoney 3rd J, Finomore V, Marton J, Ramadan J, Hodder S, Thompson-Lake D Drug Alcohol Depend. 2023; 249:110817.
PMID: 37331302 PMC: 10416187. DOI: 10.1016/j.drugalcdep.2023.110817.
Jing F, Li Z, Qiao S, Ning H, Zhou S, Li X Health Place. 2023; 83:103055.
PMID: 37311276 PMC: 10527759. DOI: 10.1016/j.healthplace.2023.103055.